Home/Filings/4/0001567619-22-012481
4//SEC Filing

O'Neil Thomas P. 4

Accession 0001567619-22-012481

CIK 0001692830other

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 5:40 PM ET

Size

5.6 KB

Accession

0001567619-22-012481

Insider Transaction Report

Form 4
Period: 2022-06-03
O'Neil Thomas P.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-03+190,000190,000 total
    Exercise: $3.46Exp: 2032-06-02Common Stock (190,000 underlying)
Footnotes (1)
  • [F1]Twenty Five Percent (25%) of the shares subject to the option vest one year measured from June 3, 2022 and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Documents

1 file

Issuer

Satsuma Pharmaceuticals, Inc.

CIK 0001692830

Entity typeother

Related Parties

1
  • filerCIK 0001640645

Filing Metadata

Form type
4
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 5:40 PM ET
Size
5.6 KB